← 홈

고형암 (전체)

911개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 911개
ADCBiologicstaleZai Lab (Shanghai) Co., Ltd.Phase 1

ZL-6201 (ZL-6201)

Solid Tumors; Sarcomas · Solid Tumors

#SolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1b)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleHoffmann-La RochePhase 2

trastuzumab (Herceptin, ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase 1c)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW171 (ZW171)

Mesothelin-expressing Advanced Cancers · Mesothelin-expressing Advanced Cancers

#Mesothelin-expressingAdvancedCan#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW191 (ZW191)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleZymeworks BC Inc.Phase 1

ZW251 (ZW251)

Hepatocellular Carcinoma; Squamous Cell Non-Small Cell Lung Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleNational Cancer Institute (NCI)Phase 1

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Ziv-Aflibercept)

Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Colorectal Carcinoma · FRα

#FR#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 1

[225Ac]-FPI-2068 ([225Ac]-FPI-2068)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleVanderbilt-Ingram Cancer CenterPhase 1

[68Ga]Ga-ABY-025 ([68Ga]Ga-ABY-025)

Locally Advanced Cancer; Metastatic Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
CGTBiologicstaleBeijing 302 HospitalPhase 2

allogeneic NK cells therapy (allogeneic NK cells therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Cell Therapy Research …Phase 2

anti-CTLA-4/PD-1 expressing EGFR-CAR-T (anti-CTLA-4/PD-1 expressing EGFR-CAR-T)

Advanced Solid Tumor · EGFR

#EGFR#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleTongji HospitalPreclinical

apatinib plus camrelizumab (apatinib plus camrelizumab)

Hepatocellular Carcinoma Non-resectable · Hepatocellular Carcinoma Non-resectable

#HepatocellularCarcinomaNon-resec#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleAeon Therapeutics (Shanghai) Co…Phase 1

autologous ET1402L1-CART cells (autologous ET1402L1-CART cells)

Hepatocellular Carcinoma; Liver Cancer · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 1

bevacizumab with chemotherapy, Pleur-XTM catheter placement (bevacizumab with chemotherapy, Pleur-XTM catheter placement)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

cTACE+Atirizumab+Bevacizumab (cTACE+Atirizumab+Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleCentre Francois BaclesseApproved

nivolumab (Opdivo, cabozantinib and nivolumab)

Renal Cell Carcinoma (Kidney Cancer); Metastatic Renal Cell Carcinoma · Renal Cell Carcinoma (Kidney Cancer)

#RenalCellCarcinomaKidneyCancer#Antibody#Approved#항체#면역항체+3
효능 ORR 25%임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

cetuximab (CTX, cetuximab, cetuximab (CTX) or nimotuzumab (NTZ))

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cohort C2 Only (cetuximab, cetuximab (Cohort C2 Only))

Advanced Solid Tumors; Metastatic Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

docetaxel, cisplatin, 5-fluorouracil (cetuximab and chemotherapy, cetuximab and chemotherapy (docetaxel, cisplatin, 5-fluorouracil))

Esophageal Carcinoma · Esophageal Carcinoma

#EsophagealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyBiologicstaleEli LillyPhase 3

pembrolizumab (Keytruda, cetuximab+PD-1 mAb, Pembrolizumab/Finotonlimab, cetuximab+PD-1 mAb(Pembrolizumab/Finotonlimab)+chemotherapy)

Squamous Cell Carcinoma of Head and Neck · PD-1

#PD-1#Antibody#Phase3#항체#면역항체+3
효능 ORR 0%임상시험 1상태 RECRUITING

44 / 46 페이지

← 이전다음 →